Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever

LUO Duan-De; WANG Xin-He; CAI Shu-Qing; LIU Shi-Wei; WEI Ke-Qi; JIA Jin-Sheng; CHANG Quan-Hai; ZHENG Ji-Ying; FAN Mu-Sheng

PDF
Cite
Share

facebook

twitter

google

linkedin

June 1988

LUO Duan-De, WANG Xin-He, CAI Shu-Qing, LIU Shi-Wei, WEI Ke-Qi, JIA Jin-Sheng, CHANG Quan-Hai, ZHENG Ji-Ying and FAN Mu-Sheng. Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever[J]. Virologica Sinica, 1988, 3(3).

Citation: LUO Duan-De, WANG Xin-He, CAI Shu-Qing, LIU Shi-Wei, WEI Ke-Qi, JIA Jin-Sheng, CHANG Quan-Hai, ZHENG Ji-Ying, FAN Mu-Sheng. Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever .VIROLOGICA SINICA, 1988, 3(3) : 290.

流行性出血热抗病毒治疗的探讨

1.
同济医科大学附属协和医院
2.
黄陂县人民医院
3.
监利县人民医院
4.
监利县人民医院武汉

摘要

本文报告105例流行性出血热早期患者,随机分为治疗组与对照组,治疗组应用广谱抗病毒药物病毒唑治疗,对照组为对症治疗,结果发现治疗组较对照组退热和尿蛋白消失时间明显缩短,同时越过低血压休克期和少尿期者明显增加,且特异性循环免疫复合物消失比对照组快。说明抗病毒药物—病毒唑治疗流行性出血热早期患者是有效的。

Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever

1.
Department of Iufections Disease
2.
Union Hospital
3.
Tongji Medieal University
4.
Wuhan

Abstract

105 cases of Epidemic Hemorrhagic Fever (EHF) were randomly divided into 2 groups, 62 cases were treated with ribavirin and 43 cases served as control. The study group received ribavirin 700-800mg/day iv infusion for 3 days, while the control group was treated with symptomatic therapy only. In the study group fever lowered and albuminuria disappeared more rapidly, other clinical symptoms were recovered much quicker and specific circulating immune complexes persisted shorter. These results showed that ribavi...

References
Proportional views

PDF

Article Metrics

Article views(3474) PDF downloads(682) Cited by(0)

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Studies on Antiviral Therapy of Epidemic Hemorrhagic Fever

1. Department of Iufections Disease
2. Union Hospital
3. Tongji Medieal University
4. Wuhan

Abstract: 105 cases of Epidemic Hemorrhagic Fever (EHF) were randomly divided into 2 groups, 62 cases were treated with ribavirin and 43 cases served as control. The study group received ribavirin 700-800mg/day iv infusion for 3 days, while the control group was treated with symptomatic therapy only. In the study group fever lowered and albuminuria disappeared more rapidly, other clinical symptoms were recovered much quicker and specific circulating immune complexes persisted shorter. These results showed that ribavi...